These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5527169)

  • 61. Serotonergic involvement with neuroleptic catalepsy.
    Costall B; Fortune DH; Naylor RJ; Mardsen CD; Pycock C
    Neuropharmacology; 1975 Nov; 14(11):859-68. PubMed ID: 1239697
    [No Abstract]   [Full Text] [Related]  

  • 62. [Study on the extrapyramidal system from the standpoint of pharmacology and psychopharmacology].
    Hara S
    Zasshi Tokyo Ika Daigaku; 1969 Jan; 27(1):1-22. PubMed ID: 4978901
    [No Abstract]   [Full Text] [Related]  

  • 63. [Critical study of a method for quick selection of long-acting neuroleptics in the rat].
    Puech AJ; Chermat R; Malatray J; Simon P
    Therapie; 1973; 28(4):753-63. PubMed ID: 4793690
    [No Abstract]   [Full Text] [Related]  

  • 64. [Effect of antidepressants and neuroleptics on the behavioral reactions evoked by destruction and stimulation of the hippocampus].
    Allikmets LKh
    Farmakol Toksikol; 1973; 36(5):664-7. PubMed ID: 4802185
    [No Abstract]   [Full Text] [Related]  

  • 65. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
    Olds ME; Jacques DB; Kpoyov O
    Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [On some antagonists of meprobamate in relation to its ataraxic and muscle relaxant effect].
    Vikhliaev IuI; Klygul TA
    Farmakol Toksikol; 1968; 31(6):660-4. PubMed ID: 5713575
    [No Abstract]   [Full Text] [Related]  

  • 67. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 68. [Experimental neuropathological syndromes during the development of hyperactive determinant dispatch stations in the caudate nuclei].
    Kryzhanovskiĭ GN; Aliev MN
    Biull Eksp Biol Med; 1976; 81(4):397-9. PubMed ID: 945093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Methodical problems in experimental studies of neuroleptics.
    Metys J; Metysová J; Dlabac A; Votava Z
    Act Nerv Super (Praha); 1972; 14(2):122-3. PubMed ID: 5040157
    [No Abstract]   [Full Text] [Related]  

  • 71. The role of caudate nucleus in dermorphin-induced catalepsy in rats.
    Improta G; Guglietta A
    Peptides; 1985; 6 Suppl 3():161-4. PubMed ID: 3831960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

  • 73. Behavioral changes as a result of dotarizine or flunarizine influence on dopaminergic neurotransmission in the striatum.
    Petkov VD; Petkova B
    Acta Physiol Pharmacol Bulg; 1998; 23(1):21-5. PubMed ID: 10347616
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats [proceedings].
    Carter CJ; Pycock CJ
    Br J Pharmacol; 1977 Jun; 60(2):267P-268P. PubMed ID: 560233
    [No Abstract]   [Full Text] [Related]  

  • 75. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of neuroleptics on brain amphetamine concentrations in the rat.
    Lal S; Missala K; Sourkes T
    J Pharm Pharmacol; 1971 Dec; 23(12):967-9. PubMed ID: 4402025
    [No Abstract]   [Full Text] [Related]  

  • 78. Synthesis and pharmacological investigations of new 6-oxo-1,2,3,4-tetrahydro-6H-pyrimido[2,1-b]quinazoline derivatives.
    Korzycka L; Szadowska A; Pakulska W
    Pharmazie; 1994 Nov; 49(11):815-9. PubMed ID: 7838867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Rat's nigrostriatal dopamine system under the influence of insulin in alloxan diabetes].
    Majewski K; Braszko J; Wiśniewski K
    Psychiatr Pol; 1993; 27(3):325-35. PubMed ID: 8356179
    [No Abstract]   [Full Text] [Related]  

  • 80. [Nonuniform effect of cataleptogenic and atypical neuroleptics on the turning reactions induced by stimulation of the putamen and caudate nucleus in cats].
    Anokhov SS; Arushanian EB
    Farmakol Toksikol; 1984; 47(6):16-20. PubMed ID: 6151517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.